Riverhead Capital Management’s Amedisys AMED Stock Holding History

Riverhead Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$426K	Hold	3,253	–	–	0.02%	784
2019 Q2	$395K	Hold	3,253	–	–	0.01%	826
2019 Q1	$401K	Hold	3,253	–	–	0.02%	809
2018 Q4	$381K	Hold	3,253	–	–	0.02%	763
2018 Q3	$407K	Buy	3,253 +800	+33%	+$88.3K	0.01%	861
2018 Q2	$210K	Hold	2,453	–	–	0.01%	1068
2018 Q1	$148K	Hold	2,453	–	–	0.01%	1208
2017 Q4	$129K	Buy	2,453 +200	+9%	+$10.5K	0.01%	1250
2017 Q3	$126K	Buy	2,253 +322	+17%	+$17K	0.01%	1197
2017 Q2	$121K	Buy	1,931 +831	+76%	+$48.4K	0.01%	1151
2017 Q1	$56K	Sell	1,100 -100	-8%	-$4.77K	﹤0.01%	1232
2016 Q4	$51K	Hold	1,200	–	–	﹤0.01%	1231
2016 Q3	$57K	Sell	1,200 -9,196	-88%	-$459K	﹤0.01%	1138
2016 Q2	$7.44M	Buy	10,396 +4,253	+69%	+$215K	0.24%	125
2016 Q1	$297K	Sell	6,143 -1,657	-21%	-$63.9K	﹤0.01%	1116
2015 Q4	$307K	Buy	7,800 +5,500	+239%	+$220K	﹤0.01%	1130
2015 Q3	$87K	Buy	+2,300	New	+$97K	﹤0.01%	1145

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Riverhead Capital Management's AMED Position: Q3 2019 in Review

Riverhead Capital Management held its Amedisys (AMED) position steady in Q3 2019 at 3,253 shares worth $426K. The position accounts for 0.02% of the portfolio, ranked #784.

Riverhead Capital Management first reported a position in AMED in Q3 2015 and has held it in 17 quarters since. The position peaked at $7.44M in Q2 2016. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

Riverhead Capital Management held 3,253 shares of Amedisys worth $426K as of Q3 2019.
Riverhead Capital Management left its Amedisys share count unchanged in Q3 2019.
Amedisys made up 0.02% of Riverhead Capital Management's portfolio in Q3 2019, its #784 holding.
Riverhead Capital Management first reported a position in Amedisys in Q3 2015 and has held it in 17 quarters since.
Riverhead Capital Management's Amedisys position peaked at $7.44M in Q2 2016.
283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.